Pulmonary Arterial Hypertension (PAH)

Select from the various topics below and click on the link to get an inside view of how our P&T committee responded to the issue. 

Preferred Tier 4 Agents – Talk of preferring agents within tier 4

Endothelin Agonists vs. PDE-5 – Committee asks specialist what he prefers to use first-line

Community Pulmonologist – Discusses the type of PAH he sees in his patients

Revatio superiority – Revatio superior to other agents in arterial oxygenation and unsure whether this is a class effect


* PTP video clips play in windows media player.  To download click here, Mac users click here
 


top of page